Search Results 9341-9350 of 42404 for oral

  1. Letrozole After Tamoxifen in Treating Women With Breast Cancer - Mayo Clinic

    Adequate oral intake. PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified. Chemotherapy: Prior adjuvant chemotherapy allowed; No concurrent chemotherapy.

  2. Mayo Clinic Q and A: Successful conception and delivery with a heart issue

    If you have had a heart valve replaced with a mechanical heart valve, this poses a particular problem during pregnancy because the oral medication typically ...

  3. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...

  4. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Neurology · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric ...

  5. A Study Of Sonodynamic Therapy Using SONALA-001 And Exablate 4000 Type 2.0 In Subjects With Recurrent GBM - Mayo Clinic

    Acceptable forms of birth control include hormonal contraceptives (oral, injectable, transdermal, or intravaginal) or intrauterine device (IUD) for at least ...

  6. ... ORAL DISEASES WITH MCC,42480.44 MS158,DENTAL AND ORAL DISEASES WITH CC,20142.03 MS163,MAJOR CHEST PROCEDURES WITH MCC,148780.4 MS164,MAJOR CHEST ...

  7. Advancing science through medical education - Mayo Clinic

    Garica presented the study results as an oral presentation at CHEST 2023 in Hawaii. "These findings may inform the development of standardized operating ...

  8. Publications - Nagarajan Kannan, Ph.D., M.S. - Mayo Clinic

    Oral Toxicities of PSMA-Targeted Therapies: Mitigation Strategies and Translational Opportunities. Clin Genitourin Cancer. 2025 Oct 6; 23 (6):102452 Epub ...

  9. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

    Patients must not have an active infection requiring oral or IV antibiotics within 14 days prior to registration; patients receiving prophylactic ...

  10. Trial Of Eltrombopag During Consolidation Therapy In Adults With AML In Complete Remission - Mayo Clinic

    Eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, has been shown to increase platelet counts in adults with chronic immune thrombocytopenia ...